Press Releases
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a multi-project collaboration with Otsuka Pharmaceutical Co.,...
Clinical Trials
Epizyme Announces U.S. FDA Approval of TAZVERIK for the Treatment of Patients with Epithelioid Sarcoma
Epizyme, Inc., a biopharmaceutical company developing novel epigenetic therapies, announced that the U.S. FDA has granted accelerated approval of TAZVERIK for the treatment of...
Drug Research
Predictive Oncology Acquire Quantitative Medicine and an AI Engine that Facilitates Accelerated Drug Discovery and Development
Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, announces it has signed a letter...
Press Releases
Bormioli pharma unveils at Pharmapack Europe new products and services
Bormioli Pharma, leading global producer in the pharma packaging market, will attend Pharmapack Europe, one of the leading European events dedicated to pharmaceutical packaging,...
Press Releases
Aptar Pharma’s Nasal Unidose Device Approved by US FDA for New Nasal Seizure Rescue Treatment
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, announced that its patented Unidose Liquid System is the device...
Clinical Trials
Greenphire Expands ConneX Global Travel Solution to Further Support Clinical Trial Participation and Retention Worldwide
Greenphire, the global leader in financial software for clinical trials, announced that it has expanded its ConneX global travel solution to include additional in-market...
Drug Research
FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go global” and promote the innovation and development of industry
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read